David H. Mack - Jan 18, 2024 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ David H. Mack
Stock symbol
PMVP
Transactions as of
Jan 18, 2024
Transactions value $
$0
Form type
4
Date filed
1/22/2024, 04:02 PM
Previous filing
Nov 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Award $0 +164K +58.83% $0.00 442K Jan 18, 2024 Direct F1
holding PMVP Common Stock 165K Jan 18, 2024 See footnote F2
holding PMVP Common Stock 148K Jan 18, 2024 See footnote F2, F3
holding PMVP Common Stock 57K Jan 18, 2024 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Award $0 +520K $0.00 520K Jan 18, 2024 Common Stock 520K $1.80 Direct F4

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 30, 2025.
F2 The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F3 The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F4 Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024.

Remarks:

Exhibit 24 - Power of Attorney